Peter A. McCullough, MD, MPH™ – Telegram
Peter A. McCullough, MD, MPH
27.1K subscribers
747 photos
611 videos
14 files
4.99K links
Physician-scientist, author, commentator, Chief Scientific Officer, The Wellness Company, President, McCullough Foundation, www.petermcculloughmd.com
Download Telegram
On Monday, the FDA “approved” the Pfizer COVID-19 (which will be marketed as COMIRNATY) “for the prevention of COVID-19 disease in individuals 16 years of age and older.”

If you want an “approved” dose of COMIRNATY – too bad. It’s not yet available. You can still get the Pfizer Vaccine authorized under the Emergency Use Authorization, however. Much has been discussed about whether this is a real “approval” – and I won’t repeat that. I’ll walk through the source documents and data, showing just how weak this purported approval really is.

The Effectiveness is “unknown.”

The FDA says COMIRNATY is “safe and effective in preventing COVID-19 in individuals 16 years of age and older.” How effective? They state (~6 months after dose 2) that it is “91% effective in preventing COVID-19 disease,” citing to a study where Pfizer observed “77 cases of COVID-19 occurring in the vaccine group.”

This leaves us with an important question. The Pfizer study is from a “follow-up through March 13, 2021.” That is over 5 months ago. Is the FDA using outdated data in support of the COMIRNATY approval?

In other words, how long does the effectiveness really last?

Pfizer has an answer for us. According to its August 23, 2021 fact sheet, “The duration of protection against COVID-19 is currently unknown.”
Village Seventh-day Adventist Church Berrien Springs MI, Coercion & Conscience Weekend https://www.youtube.com/watch?v=HEQMuioVjjo
Are pregnant women given enough informed consent in the risk-benefit analysis of the vaccine vs. the virus?

OP-ED

DANIEL HOROWITZ

AUGUST 27, 2021